The following are published studies that define and demonstrate the effectiveness of the VALITEQ Aseptic Technique Verification System in supporting the CSP process:
Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding.
Trissel, L. A., et.al. Vol 62. 285-288, American Journal of Health-system Pharmacy (AJHP), February 2005
Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
Peters, G. F., et al. Vol. 64, 622-631, American Journal of Health-system Pharmacy (AJHP), March 2007
Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
Trissel, L. A., et.al. Vol. 64, 837-841, American Journal of Health-system Pharmacy (AJHP), April 2007
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study.
Peters, G. F., et. al. Vol. 11-6, International Journal of Pharmaceutical Compounding (IJPC), November - December 2007
Instructional Design and Assessment: Parenterals Laboratory Course to Reduce Microbial Contamination Rates in Media Fill Tests Performed by Pharmacy Students
Christine M. Isanhart, PharmD, et al. 72(2), 1-4, Article 27, American Journal of Pharmaceutical Education, April 2008
Laminar Airflow Equipment Theory and Applications
Peters, G. F. and Swarbrick J., ed. Third Edition, Vol. 4, Encyclopedia of Pharmaceutical Technology, 2007
Microbiologic Monitoring of Controlled Processes
Peters, G. F., McKeon, M. and Swarbrick J., ed. Third Edition, Vol. 4, Encyclopedia of Pharmaceutical Technology, 2007
The ASHP Discussion Guide on USP Chapter <797> for Compounding Steril Preparations
A Practical Guide to Aseptic Technique Verification: Policies and Procedures that Meet USP Chapter <797> Requirements
Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings
CETA Compounding Isolator Testing Guide
USP Pharmaceutical Compounding – Sterile Preparations General Chapter <797>